|
1
|
Nguyen HX and Bursac N: Ion channel
engineering for modulation and de novo generation of electrical
excitability. Curr Opin Biotechnol. 58:100–107. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Capatina AL, Lagos D and Brackenbury WJ:
Targeting ion channels for cancer treatment: Current progress and
future challenges. Rev Physiol Biochem Pharmacol. 183:1–43.
2022.
|
|
3
|
Bulk E, Todesca LM and Schwab A: Ion
channels in lung cancer. Rev Physiol Biochem Pharmacol. 181:57–79.
2021. View Article : Google Scholar
|
|
4
|
Xiao F, Yu Q, Li J, Johansson ME, Singh
AK, Xia W, Riederer B, Engelhardt R, Montrose M, Soleimani M, et
al: Slc26a3 deficiency is associated with loss of colonic HCO3 (-)
secretion, absence of a firm mucus layer and barrier impairment in
mice. Acta Physiol (Oxf). 211:161–175. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zahn A, Moehle C, Langmann T, Ehehalt R,
Autschbach F, Stremmel W and Schmitz G: Aquaporin-8 expression is
reduced in ileum and induced in colon of patients with ulcerative
colitis. World J Gastroenterol. 13:1687–1695. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu H, Zhang B, Li J, Wang C, Chen H and
Ghishan FK: Impaired mucin synthesis and bicarbonate secretion in
the colon of NHE8 knockout mice. Am J Physiol Gastrointest Liver
Physiol. 303:G335–G343. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Singh AK, Sjöblom M, Zheng W, Krabbenhöft
A, Riederer B, Rausch B, Manns MP, Soleimani M and Seidler U: CFTR
and its key role in in vivo resting and luminal acid-induced
duodenal HCO3-secretion. Acta Physiol (Oxf). 193:357–365. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schultheis PJ, Clarke LL, Meneton P,
Harline M, Boivin GP, Stemmermann G, Duffy JJ, Doetschman T, Miller
ML and Shull GE: Targeted disruption of the murine Na+/H+ exchanger
isoform 2 gene causes reduced viability of gastric parietal cells
and loss of net acid secretion. J Clin Invest. 101:1243–1253. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang A, Li J, Zhao Y, Johansson ME, Xu H
and Ghishan FK: Loss of NHE8 expression impairs intestinal mucosal
integrity. Am J Physiol Gastrointest Liver Physiol. 309:G855–G864.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Boivin GP, Schultheis PJ, Shull GE and
Stemmermann GN: Variant form of diffuse corporal gastritis in NHE2
knockout mice. Comp Med. 50:511–515. 2000.PubMed/NCBI
|
|
11
|
Ding X, Li D, Li M, Wang H, He Q, Wang Y,
Yu H, Tian D and Yu Q: SLC26A3 (DRA) prevents TNF-alpha-induced
barrier dysfunction and dextran sulfate sodium-induced acute
colitis. Lab Invest. 98:462–476. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang W, Xu Y, Chen Z, Xu Z and Xu H:
Knockdown of aquaporin 3 is involved in intestinal barrier
integrity impairment. FEBS Lett. 585:3113–3119. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moeser AJ, Nighot PK, Ryan KA, Simpson JE,
Clarke LL and Blikslager AT: Mice lacking the Na+/H+ exchanger 2
have impaired recovery of intestinal barrier function. Am J Physiol
Gastrointest Liver Physiol. 295:G791–G797. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kumar A, Priyamvada S, Ge Y, Jayawardena
D, Singhal M, Anbazhagan AN, Chatterjee I, Dayal A, Patel M, Zadeh
K, et al: A novel role of SLC26A3 in the maintenance of intestinal
epithelial barrier integrity. Gastroenterology. 160:1240–1255.e3.
2021. View Article : Google Scholar
|
|
15
|
Doi K, Nagao T, Kawakubo K, Ibayashi S,
Aoyagi K, Yano Y, Yamamoto C, Kanamoto K, Iida M, Sadoshima S and
Fujishima M: Calcitonin gene-related peptide affords gastric
mucosal protection by activating potassium channel in Wistar rat.
Gastroenterology. 114:71–76. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Deng Z, Zhao Y, Ma Z, Zhang M, Wang H, Yi
Z, Tuo B, Li T and Liu X: Pathophysiological role of ion channels
and transporters in gastrointestinal mucosal diseases. Cell Mol
Life Sci. 78:8109–8125. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pallagi P, Hegyi P and Rakonczay Z Jr: The
physiology and pathophysiology of pancreatic ductal secretion: The
background for clinicians. Pancreas. 44:1211–1233. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ishiguro H, Yamamoto A, Nakakuki M, Yi L,
Ishiguro M, Yamaguchi M, Kondo S and Mochimaru Y: Physiology and
pathophysiology of bicarbonate secretion by pancreatic duct
epithelium. Nagoya J Med Sci. 74:1–18. 2012.PubMed/NCBI
|
|
19
|
Novak I, Haanes KA and Wang J: Acid-base
transport in pancreas-new challenges. Front Physiol. 4:3802013.
View Article : Google Scholar
|
|
20
|
Schnipper J, Dhennin-Duthille I, Ahidouch
A and Ouadid-Ahidouch H: Ion channel signature in healthy pancreas
and pancreatic ductal adenocarcinoma. Front Pharmacol.
11:5689932020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen X, Zhang L, Zheng L and Tuo B: Role
of Ca(2+) channels in non-alcoholic fatty liver disease and their
implications for therapeutic strategies (Review). Int J Mol Med.
50:1132022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stock C: How dysregulated ion channels and
transporters take a hand in esophageal, liver, and colorectal
cancer. Rev Physiol Biochem Pharmacol. 181:129–222. 2021.
View Article : Google Scholar
|
|
23
|
Li W, Wang C, Peng X, Zhang H, Huang H and
Liu H: CFTR inhibits the invasion and growth of esophageal cancer
cells by inhibiting the expression of NF-κB. Cell Biol Int.
42:1680–1687. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Goldman A, Chen H, Khan MR, Roesly H, Hill
KA, Shahidullah M, Mandal A, Delamere NA and Dvorak K: The
Na+/H+ exchanger controls deoxycholic
acid-induced apoptosis by a H+-activated,
Na+-dependent ionic shift in esophageal cells. PLoS One.
6:e238352011. View Article : Google Scholar
|
|
25
|
Boult J, Roberts K, Brookes MJ, Hughes S,
Bury JP, Cross SS, Anderson GJ, Spychal R, Iqbal T and Tselepis C:
Overexpression of cellular iron import proteins is associated with
malignant progression of esophageal adenocarcinoma. Clin Cancer
Res. 14:379–387. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gao N, Yang F, Chen S, Wan H, Zhao X and
Dong H: The role of TRPV1 ion channels in the suppression of
gastric cancer development. Exp Clin Cancer Res. 39:2062020.
View Article : Google Scholar
|
|
27
|
Chang Y, Roy S and Pan Z: Store-operated
calcium channels as drug target in gastroesophageal cancers. Front
Pharmacol. 12:6687302021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Csekő K, Pécsi D, Kajtár B, Hegedűs I,
Bollenbach A, Tsikas D, Szabó IL, Szabó S and Helyes Z:
Upregulation of the TRPA1 Ion channel in the gastric mucosa after
iodoacetamide-induced gastritis in rats: A potential new
therapeutic target. Int J Mol Sci. 21:55912020. View Article : Google Scholar
|
|
29
|
Capurro MI, Greenfield LK, Prashar A, Xia
S, Abdullah M, Wong H, Zhong XZ, Bertaux-Skeirik N, Chakrabarti J,
Siddiqui I, et al: VacA generates a protective intracellular
reservoir for Helicobacter pylori that is eliminated by activation
of the lysosomal calcium channel TRPML1. Nat Microbiol.
4:1411–1423. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang L, Zhang Y, Jiang Y, Dou X, Li S,
Chai H, Qian Q and Wang M: Upregulated SOCC and IP3R calcium
channels and subsequent elevated cytoplasmic calcium signaling
promote nonalcoholic fatty liver disease by inhibiting autophagy.
Mol Cell Biochem. 476:3163–3175. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Swain SM, Romac JM, Shahid RA, Pandol SJ,
Liedtke W, Vigna SR and Liddle RA: TRPV4 channel opening mediates
pressure-induced pancreatitis initiated by Piezo1 activation. J
Clin Invest. 130:2527–2541. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin R, Bao X, Wang H, Zhu S, Liu Z, Chen
Q, Ai K and Shi B: TRPM2 promotes pancreatic cancer by PKC/MAPK
pathway. Cell Death Dis. 12:5852021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li S, Han J, Guo G, Sun Y, Zhang T, Zhao
M, Xu Y, Cui Y, Liu Y and Zhang J: Voltage-gated sodium channels β3
subunit promotes tumorigenesis in hepatocellular carcinoma by
facilitating p53 degradation. FEBS Lett. 594:497–508. 2020.
View Article : Google Scholar
|
|
34
|
Nattramilarasu PK, Bücker R, Lobo de Sá
FD, Fromm A, Nagel O, Lee IM, Butkevych E, Mousavi S, Genger C,
Kløve S, et al: Campylobacter concisus impairs sodium absorption in
colonic epithelium via ENaC dysfunction and claudin-8 disruption.
Int J Mol Sci. 21:3732020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gao F, Wang D, Liu X, Wu YH, Wang HT and
Sun SL: Sodium channel 1 subunit alpha SCNN1A exerts oncogenic
function in pancreatic cancer via accelerating cellular growth and
metastasis. Arch Biochem Biophys. 727:1093232022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang H, Li C, Peng M, Wang L, Zhao D, Wu
T, Yi D, Hou Y and Wu G: N-Acetylcysteine improves intestinal
function and attenuates intestinal autophagy in piglets challenged
with β-conglycinin. Sci Rep. 11:12612021. View Article : Google Scholar
|
|
37
|
Goswami S: Interplay of potassium channel,
gastric parietal cell and proton pump in gastrointestinal
physiology, pathology and pharmacology. Minerva Gastroenterol
(Torino). 68:289–305. 2022.
|
|
38
|
Patel SH, Edwards MJ and Ahmad SA:
Intracellular ion channels in pancreas cancer. Cell Physiol
Biochem. 53:44–51. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Schroeder BC, Waldegger S, Fehr S, Bleich
M, Warth R, Greger R and Jentsch TJ: A constitutively open
potassium channel formed by KCNQ1 and KCNE3. Nature. 403:196–199.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ponnalagu D and Singh H: Anion channels of
mitochondria. Handb Exp Pharmacol. 240:71–101. 2017. View Article : Google Scholar
|
|
41
|
Gururaja Rao S, Ponnalagu D, Patel NJ and
Singh H: Three decades of chloride intracellular channel proteins:
From organelle to organ physiology. Curr Protoc Pharmacol.
80:11.21.1–11.21.17. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kouyoumdzian NM, Kim G, Rudi MJ, Rukavina
Mikusic NL, Fernández BE and Choi MR: Clues and new evidences in
arterial hypertension: Unmasking the role of the chloride anion.
Pflugers Arch. 474:155–176. 2022. View Article : Google Scholar
|
|
43
|
Jentsch TJ and Pusch M: CLC chloride
channels and transporters: Structure, function, physiology, and
disease. Physiol Rev. 98:1493–1590. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shi J, Shi S, Yuan G, Jia Q, Shi S, Zhu X,
Zhou Y, Chen T and Hu Y: Bibliometric analysis of chloride channel
research (2004-2019). Channels (Austin). 14:393–402. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jentsch TJ, Stein V, Weinreich F and
Zdebik AA: Molecular structure and physiological function of
chloride channels. Physiol Rev. 82:503–568. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Peng F, Wu Y, Dong X and Huang P:
Proton-activated chloride channel: Physiology and disease. Front
Biosci (Landmark Ed). 28:112023. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Patil VM and Gupta SP: Studies on chloride
channels and their modulators. Curr Top Med Chem. 16:1862–1876.
2016. View Article : Google Scholar
|
|
48
|
Accardi A and Miller C: Secondary active
transport mediated by a prokaryotic homologue of ClC Cl- hannels.
Nature. 427:803–807. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Jentsch TJ: CLC chloride channels and
transporters: From genes to protein structure, pathology and
physiology. Crit Rev Biochem Mol Biol. 43:3–36. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yang YD, Cho H, Koo JY, Tak MH, Cho Y,
Shim WS, Park SP, Lee J, Lee B, Kim BM, et al: TMEM16A confers
receptor-activated calcium-dependent chloride conductance. Nature.
455:1210–1215. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Caputo A, Caci E, Ferrera L, Pedemonte N,
Barsanti C, Sondo E, Pfeffer U, Ravazzolo R, Zegarra-Moran O and
Galietta LJ: TMEM16A, a membrane protein associated with
calcium-dependent chloride channel activity. Science. 322:590–594.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Gadsby DC, Vergani P and Csanády L: The
ABC protein turned chloride channel whose failure causes cystic
fibrosis. Nature. 440:477–483. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Riordan JR, Rommens JM, Kerem B, Alon N,
Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, et
al: Identification of the cystic fibrosis gene: Cloning and
characterization of complementary DNA. Science. 245:1066–1073.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ullrich F, Blin S, Lazarow K, Daubitz T,
von Kries JP and Jentsch TJ: Identification of TMEM206 proteins as
pore of PAORAC/ASOR acid-sensitive chloride channels. Elife.
8:e491872019. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Olsen RW and Sieghart W: International
Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A)
receptors: Classification on the basis of subunit composition,
pharmacology, and function. Update. Pharmacol Rev. 60:243–260.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Lynch JW: Molecular structure and function
of the glycine receptor chloride channel. Physiol Rev.
84:1051–1095. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Peng JM, Lin SH, Yu MC and Hsieh SY: CLIC1
recruits PIP5K1A/C to induce cell-matrix adhesions for tumor
metastasis. J Clin Invest. 131:e1335252021. View Article : Google Scholar :
|
|
58
|
Bi MM, Hong S, Zhou HY, Wang HW, Wang LN
and Zheng YJ: Chloride channelopathies of ClC-2. Int J Mol Sci.
15:218–249. 2013. View Article : Google Scholar
|
|
59
|
Okada Y, Okada T, Sato-Numata K, Islam MR,
Ando-Akatsuka Y, Numata T, Kubo M, Shimizu T, Kurbannazarova RS,
Marunaka Y and Sabirov RZ: Cell volume-activated and
volume-correlated anion channels in mammalian cells: Their
biophysical, molecular, and pharmacological properties. Pharmacol
Rev. 71:49–88. 2019. View Article : Google Scholar
|
|
60
|
Fu D, Cui H and Zhang Y: Lack of ClC-2
alleviates high fat diet-induced insulin resistance and
non-alcoholic fatty liver disease. Cell Physiol Biochem.
45:2187–2198. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Blikslager AT, Moeser AJ, Gookin JL, Jones
SL and Odle J: Restoration of barrier function in injured
intestinal mucosa. Physiol Rev. 87:545–564. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Gehren AS, Rocha MR, de Souza WF and
Morgado-Díaz JA: Alterations of the apical junctional complex and
actin cytoskeleton and their role in colorectal cancer progression.
Tissue Barriers. 3:e10176882015. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Nighot PK, Moeser AJ, Ryan KA, Ghashghaei
T and Blikslager AT: ClC-2 is required for rapid restoration of
epithelial tight junctions in ischemic-injured murine jejunum. Exp
Cell Res. 315:110–118. 2009. View Article : Google Scholar
|
|
64
|
Jin Y, Ibrahim D, Magness ST and
Blikslager AT: Knockout of ClC-2 reveals critical functions of
adherens junctions in colonic homeostasis and tumorigenicity. Am J
Physiol Gastrointest Liver Physiol. 315:G966–G979. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Mrad FCC, Soares SBM, de Menezes Silva
LAW, Dos Anjos Menezes PV and Simões-E-Silva AC: Bartter's
syndrome: Clinical findings, genetic causes and therapeutic
approach. World J Pediatr. 17:31–39. 2021. View Article : Google Scholar
|
|
66
|
Andrini O, Eladari D and Picard N: ClC-K
kidney chloride channels: From structure to pathology. Handb Exp
Pharmacol. 283:35–58. 2024. View Article : Google Scholar
|
|
67
|
Mu H, Mu L and Gao J: Suppression of CLC-3
reduces the proliferation, invasion and migration of colorectal
cancer through Wnt/β-catenin signaling pathway. Biochem Biophys Res
Commun. 533:1240–1246. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Gu Z, Li Y, Yang X, Yu M, Chen Z, Zhao C,
Chen L and Wang L: Overexpression of CLC-3 is regulated by XRCC5
and is a poor prognostic biomarker for gastric cancer. J Hematol
Oncol. 11:1152018. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Cheng W, Zheng S, Li L, Zhou Q, Zhu H, Hu
J and Luo H: Chloride channel 3 (CIC-3) predicts the tumor size in
hepatocarcinoma. Acta Histochem. 121:284–288. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Huang LY, Li YJ, Li PP, Li HC and Ma P:
Aggravated intestinal apoptosis by ClC-3 deletion is lethal to mice
endotoxemia. Cell Biol Int. 42:1445–1453. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Huang LY, He Q, Liang SJ, Su YX, Xiong LX,
Wu QQ, Wu QY, Tao J, Wang JP, Tang YB, et al: ClC-3 chloride
channel/antiporter defect contributes to inflammatory bowel disease
in humans and mice. Gut. 63:1587–1595. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Stauber T, Weinert S and Jentsch TJ: Cell
biology and physiology of CLC chloride channels and transporters.
Compr Physiol. 2:1701–1744. 2012. View Article : Google Scholar
|
|
73
|
Stauber T and Jentsch TJ: Chloride in
vesicular trafficking and function. Annu Rev Physiol. 75:453–477.
2013. View Article : Google Scholar
|
|
74
|
Wartosch L, Fuhrmann JC, Schweizer M,
Stauber T and Jentsch TJ: Lysosomal degradation of endocytosed
proteins depends on the chloride transport protein ClC-7. FASEB J.
23:4056–4068. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Nicoli ER, Weston MR, Hackbarth M,
Becerril A, Larson A, Zein WM, Baker PR II, Burke JD, Dorward H,
Davids M, et al: Lysosomal storage and albinism due to effects of a
de novo CLCN7 variant on lysosomal acidification. Am J Hum Genet.
104:1127–1138. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Polovitskaya MM, Barbini C, Martinelli D,
Harms FL, Cole FS, Calligari P, Bocchinfuso G, Stella L, Ciolfi A,
Niceta M, et al: A recurrent gain-of-function mutation in CLCN6,
encoding the ClC-6 Cl(-)/H(+)-exchanger, causes early-onset
neurodegeneration. Am J Hum Genet. 107:1062–1077. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Bose S, He H and Stauber T:
Neurodegeneration upon dysfunction of endosomal/lysosomal CLC
chloride transporters. Front Cell Dev Biol. 9:6392312021.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Locher KP: Mechanistic diversity in
ATP-binding cassette (ABC) transporters. Nat Struct Mol Biol.
23:487–493. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Csanády L, Vergani P and Gadsby DC:
Structure, gating, and regulation of the CFTR anion channel.
Physiol Rev. 99:707–738. 2019. View Article : Google Scholar
|
|
80
|
Fonseca C, Bicker J, Alves G, Falcão A and
Fortuna A: Cystic fibrosis: Physiopathology and the latest
pharmacological treatments. Pharmacol Res. 162:1052672020.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Lukasiak A and Zajac M: The distribution
and role of the CFTR protein in the intracellular compartments.
Membranes (Basel). 11:8042021. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Matsumoto Y, Shiozaki A, Kosuga T, Kudou
M, Shimizu H, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H,
et al: Expression and role of CFTR in human esophageal squamous
cell carcinoma. Ann Surg Oncol. 28:6424–6436. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Zhang J, Liu X, Zeng L and Hu Y: GABRP
inhibits the progression of oesophageal cancer by regulating CFTR:
Integrating bioinformatics analysis and experimental validation.
Int J Exp Pathol. 105:118–132. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Shakir S, Echevarria C, Doe S, Brodlie M,
Ward C and Bourke SJ: Elexacaftor-tezacaftor-ivacaftor improve
gastro-oesophageal reflux and sinonasal symptoms in advanced cystic
fibrosis. J Cyst Fibros. 21:807–810. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Rowe SM, Heltshe SL, Gonska T, Donaldson
SH, Borowitz D, Gelfond D, Sagel SD, Khan U, Mayer-Hamblett N, Van
Dalfsen JM, et al: Clinical mechanism of the cystic fibrosis
transmembrane conductance regulator potentiator ivacaftor in
G551D-mediated cystic fibrosis. Am J Respir Crit Care Med.
190:175–184. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Petrov MS and Yadav D: Global epidemiology
and holistic prevention of pancreatitis. Nat Rev Gastroenterol
Hepatol. 16:175–184. 2019. View Article : Google Scholar :
|
|
87
|
Mayerle J, Sendler M, Hegyi E, Beyer G,
Lerch MM and Sahin-Tóth M: Genetics, cell biology, and
pathophysiology of pancreatitis. Gastroenterology.
156:1951–1968.e1. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Hou Y, Guan X, Yang Z and Li C: Emerging
role of cystic fibrosis transmembrane conductance regulator-an
epithelial chloride channel in gastrointestinal cancers. World J
Gastrointest Oncol. 8:282–288. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Fűr G, Bálint ER, Orján EM, Balla Z,
Kormányos ES, Czira B, Szűcs A, Kovács DP, Pallagi P, Maléth J, et
al: Mislocalization of CFTR expression in acute pancreatitis and
the beneficial effect of VX-661 + VX-770 treatment on disease
severity. J Physiol. 599:4955–4971. 2021. View Article : Google Scholar
|
|
90
|
Kim Y, Jun I, Shin DH, Yoon JG, Piao H,
Jung J, Park HW, Cheng MH, Bahar I, Whitcomb DC and Lee MG:
Regulation of CFTR bicarbonate channel activity by WNK1:
Implications for pancreatitis and CFTR-Related disorders. Cell Mol
Gastroenterol Hepatol. 9:79–103. 2020. View Article : Google Scholar
|
|
91
|
Lee MG, Ohana E, Park HW, Yang D and
Muallem S: Molecular mechanism of pancreatic and salivary gland
fluid and HCO3 secretion. Physiol Rev. 92:39–74. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Fong P: CFTR-SLC26 transporter
interactions in epithelia. Biophys Rev. 4:107–116. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Ko SB, Zeng W, Dorwart MR, Luo X, Kim KH,
Millen L, Goto H, Naruse S, Soyombo A, Thomas PJ and Muallem S:
Gating of CFTR by the STAS domain of SLC26 transporters. Nat Cell
Biol. 6:343–350. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Berg P, Svendsen SL, Sorensen MV, Larsen
CK, Andersen JF, Jensen-Fangel S, Jeppesen M, Schreiber R, Cabrita
I, Kunzelmann K and Leipziger J: Impaired renal HCO(3)(-) excretion
in cystic fibrosis. J Am Soc Nephrol. 31:1711–1727. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Ishiguro H, Steward MC, Naruse S, Ko SB,
Goto H, Case RM, Kondo T and Yamamoto A: CFTR functions as a
bicarbonate channel in pancreatic duct cells. J Gen Physiol.
133:315–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Park HW, Nam JH, Kim JY, Namkung W, Yoon
JS, Lee JS, Kim KS, Venglovecz V, Gray MA, Kim KH and Lee MG:
Dynamic regulation of CFTR bicarbonate permeability by [Cl-]i and
its role in pancreatic bicarbonate secretion. Gastroenterology.
139:620–631. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Yang CL, Liu X, Paliege A, Zhu X, Bachmann
S, Dawson DC and Ellison DH: WNK1 and WNK4 modulate CFTR activity.
Biochem Biophys Res Commun. 353:535–540. 2007. View Article : Google Scholar
|
|
98
|
Yang D, Li Q, So I, Huang CL, Ando H,
Mizutani A, Seki G, Mikoshiba K, Thomas PJ and Muallem S: IRBIT
governs epithelial secretion in mice by antagonizing the WNK/SPAK
kinase pathway. J Clin Invest. 121:956–965. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Shirakabe K, Priori G, Yamada H, Ando H,
Horita S, Fujita T, Fujimoto I, Mizutani A, Seki G and Mikoshiba K:
IRBIT, an inositol 1,4,5-trisphosphate receptor-binding protein,
specifically binds to and activates pancreas-type
Na+/HCO3-cotransporter 1 (pNBC1). Proc Natl Acad Sci USA.
103:9542–9547. 2006. View Article : Google Scholar
|
|
100
|
Park S, Shcheynikov N, Hong JH, Zheng C,
Suh SH, Kawaai K, Ando H, Mizutani A, Abe T, Kiyonari H, et al:
Irbit mediates synergy between ca(2+) and cAMP signaling pathways
during epithelial transport in mice. Gastroenterology. 145:232–241.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Pankonien I, Quaresma MC, Rodrigues CS and
Amaral MD: CFTR, cell junctions and the cytoskeleton. Int J Mol
Sci. 23:2022. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Wen G, Jin H, Deng S, Xu J, Liu X, Xie R
and Tuo B: Effects of helicobacter pylori infection on the
expressions and functional activities of human duodenal mucosal
bicarbonate transport proteins. Helicobacter. 21:536–547. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Reyes EA, Castillo-Azofeifa D, Rispal J,
Wald T, Zwick RK, Palikuqi B, Mujukian A, Rabizadeh S, Gupta AR,
Gardner JM, et al: Epithelial TNF controls cell differentiation and
CFTR activity to maintain intestinal mucin homeostasis. J Clin
Invest. 133:e1635912023. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Bhattacharya R, Blankenheim Z, Scott PM
and Cormier RT: CFTR and gastrointestinal cancers: An update. J
Pers Med. 12:8682022. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Liu H, Wu W, Liu Y, Zhang C and Zhou Z:
Predictive value of cystic fibrosis transmembrane conductance
regulator (CFTR) in the diagnosis of gastric cancer. Clinical and
investigative medicine. Clin Invest Med. 37:E226–E232. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Yamada A, Komaki Y, Komaki F, Micic D,
Zullow S and Sakuraba A: Risk of gastrointestinal cancers in
patients with cystic fibrosis: A systematic review and
meta-analysis. Lancet Oncol. 19:758–767. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Jakab RL, Collaco AM and Ameen NA:
Physiological relevance of cell-specific distribution patterns of
CFTR, NKCC1, NBCe1, and NHE3 along the crypt-villus axis in the
intestine. Am J Physiol Gastrointest Liver Physiol. 300:G82–G98.
2011. View Article : Google Scholar :
|
|
108
|
Tse CM, Yin J, Singh V, Sarker R, Lin R,
Verkman AS, Turner JR and Donowitz M: cAMP stimulates SLC26A3
activity in human colon by a CFTR-dependent mechanism that does not
require CFTR activity. Cell Mol Gastroenterol Hepatol. 7:641–653.
2019. View Article : Google Scholar :
|
|
109
|
Vernocchi P, Del Chierico F, Russo A, Majo
F, Rossitto M, Valerio M, Casadei L, La Storia A, De Filippis F,
Rizzo C, et al: Gut microbiota signatures in cystic fibrosis: Loss
of host CFTR function drives the microbiota enterophenotype. PLoS
One. 13:e02081712018. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Burke DG, Fouhy F, Harrison MJ, Rea MC,
Cotter PD, O'Sullivan O, Stanton C, Hill C, Shanahan F, Plant BJ
and Ross RP: The altered gut microbiota in adults with cystic
fibrosis. BMC Microbiol. 17:582017. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
De Lisle RC: Disrupted tight junctions in
the small intestine of cystic fibrosis mice. Cell Tissue Res.
355:131–142. 2014. View Article : Google Scholar :
|
|
112
|
Broadbent D, Ahmadzai MM, Kammala AK, Yang
C, Occhiuto C, Das R and Subramanian H: Roles of NHERF family of
PDZ-binding proteins in regulating GPCR functions. Adv Immunol.
136:353–385. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Meeker SM, Mears KS, Sangwan N,
Brittnacher MJ, Weiss EJ, Treuting PM, Tolley N, Pope CE, Hager KR,
Vo AT, et al: CFTR dysregulation drives active selection of the gut
microbiome. PLoS Pathog. 16:e10082512020. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Mulcahy EM, Cooley MA, McGuire H, Asad S,
Fazekas de St Groth B, Beggs SA and Roddam LF: Widespread
alterations in the peripheral blood innate immune cell profile in
cystic fibrosis reflect lung pathology. Immunol Cell Biol.
97:416–426. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Trigo Salado C, Leo Carnerero E and de la
Cruz Ramírez MD: Crohn's disease and cystic fibrosis: There is
still a lot to learn. Rev Esp Enferm Dig. 110:835–836. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Gabel ME, Galante GJ and Freedman SD:
Gastrointestinal and hepatobiliary disease in cystic fibrosis.
Semin Respir Crit Care Med. 40:825–841. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Maisonneuve P, Marshall BC, Knapp EA and
Lowenfels AB: Cancer risk in cystic fibrosis: A 20-year nationwide
study from the United States. J Natl Cancer Inst. 105:122–129.
2013. View Article : Google Scholar
|
|
118
|
Than BL, Linnekamp JF, Starr TK,
Largaespada DA, Rod A, Zhang Y, Bruner V, Abrahante J, Schumann A,
Luczak T, et al: CFTR is a tumor suppressor gene in murine and
human intestinal cancer. Oncogene. 35:4179–4187. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Sun TT, Wang Y, Cheng H, Xiao HZ, Xiang
JJ, Zhang JT, Yu SB, Martin TA, Ye L, Tsang LL, et al: Disrupted
interaction between CFTR and AF-6/afadin aggravates malignant
phenotypes of colon cancer. Biochim Biophys Acta. 1843:618–628.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Palma AG, Soares Machado M, Lira MC, Rosa
F, Rubio MF, Marino G, Kotsias BA and Costas MA: Functional
relationship between CFTR and RAC3 expression for maintaining
cancer cell stemness in human colorectal cancer. Cell Oncol
(Dordr). 44:627–641. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Strubberg AM, Liu J, Walker NM, Stefanski
CD, MacLeod RJ, Magness ST and Clarke LL: Cftr modulates
Wnt/β-catenin signaling and stem cell proliferation in murine
intestine. Cell Mol Gastroenterol Hepatol. 5:253–271. 2017.
View Article : Google Scholar
|
|
122
|
Liu C, Song C, Li J and Sun Q: CFTR
functions as a tumor suppressor and is regulated by DNA methylation
in colorectal cancer. Cancer Manag Res. 12:4261–4270. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Paulino C, Neldner Y, Lam AK, Kalienkova
V, Brunner JD, Schenck S and Dutzler R: Structural basis for anion
conduction in the calcium-activated chloride channel TMEM16A.
Elife. 6:e262322017. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Dang S, Feng S, Tien J, Peters CJ, Bulkley
D, Lolicato M, Zhao J, Zuberbühler K, Ye W, Qi L, et al: Cryo-EM
structures of the TMEM16A calcium-activated chloride channel.
Nature. 552:426–429. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Ji Q, Guo S, Wang X, Pang C, Zhan Y, Chen
Y and An H: Recent advances in TMEM16A: Structure, function, and
disease. J Cell Physiol. 234:7856–7873. 2019. View Article : Google Scholar
|
|
126
|
Liu Y, Liu Z and Wang K: The
Ca(2+)-activated chloride channel ANO1/TMEM16A: An emerging
therapeutic target for epithelium-originated diseases? Acta Pharm
Sin B. 11:1412–1433. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Crottès D and Jan LY: The multifaceted
role of TMEM16A in cancer. Cell Calcium. 82:1020502019. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Jang Y and Oh U: Anoctamin 1 in secretory
epithelia. Cell Calcium. 55:355–361. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Ji Q, Shi S, Guo S, Zhan Y, Zhang H, Chen
Y and An H: Activation of TMEM16A by natural product canthaxanthin
promotes gastrointestinal contraction. FASEB J. 34:13430–13444.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Stephan AB, Shum EY, Hirsh S, Cygnar KD,
Reisert J and Zhao H: ANO2 is the cilial calcium-activated chloride
channel that may mediate olfactory amplification. Proc Natl Acad
Sci USA. 106:11776–11781. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Huang WC, Xiao S, Huang F, Harfe BD, Jan
YN and Jan LY: Calcium-activated chloride channels (CaCCs) regulate
action potential and synaptic response in hippocampal neurons.
Neuron. 74:179–192. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Ha GE, Lee J, Kwak H, Song K, Kwon J, Jung
SY, Hong J, Chang GE, Hwang EM, Shin HS, et al: The
Ca(2+)-activated chloride channel anoctamin-2 mediates
spike-frequency adaptation and regulates sensory transmission in
thalamocortical neurons. Nat Commun. 7:137912016. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Vanoni S, Zeng C, Marella S, Uddin J, Wu
D, Arora K, Ptaschinski C, Que J, Noah T, Waggoner L, et al:
Identification of anoctamin 1 (ANO1) as a key driver of esophageal
epithelial proliferation in eosinophilic esophagitis. J Allergy
Clin Immunol. 145:239–254.e2. 2020. View Article : Google Scholar :
|
|
134
|
Yu Y, Cao J, Wu W, Zhu Q, Tang Y, Zhu C,
Dai J, Li Z, Wang J, Xue L, et al: Genome-wide copy number
variation analysis identified ANO1 as a novel oncogene and
prognostic biomarker in esophageal squamous cell cancer.
Carcinogenesis. 40:1198–1208. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Le SC, Jia Z, Chen J and Yang H: Molecular
basis of PIP(2)-dependent regulation of the Ca(2+)-activated
chloride channel TMEM16A. Nat Commun. 10:37692019. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Fairfield CJ, Drake TM, Pius R, Bretherick
AD, Campbell A, Clark DW, Fallowfield JA, Hayward C, Henderson NC,
Iakovliev A, et al: Genome-wide analysis identifies
gallstone-susceptibility loci including genes regulating
gastrointestinal motility. Hepatology. 75:1081–1094. 2022.
View Article : Google Scholar
|
|
137
|
Camilleri M, Sandler RS and Peery AF:
Etiopathogenetic mechanisms in diverticular disease of the colon.
Cell Mol Gastroenterol Hepatol. 9:15–32. 2020. View Article : Google Scholar
|
|
138
|
Schafmayer C, Harrison JW, Buch S, Lange
C, Reichert MC, Hofer P, Cossais F, Kupcinskas J, von Schönfels W,
Schniewind B, et al: Genome-wide association analysis of
diverticular disease points towards neuromuscular, connective
tissue and epithelial pathomechanisms. Gut. 68:854–865. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Zeng X, Pan D, Wu H, Chen H, Yuan W, Zhou
J, Shen Z and Chen S: Transcriptional activation of ANO1 promotes
gastric cancer progression. Biochem Biophys Res Commun.
512:131–136. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Xie R, Liu L, Lu X and Hu Y: LncRNA
OIP5-AS1 facilitates gastric cancer cell growth by targeting the
miR-422a/ANO1 axis. Acta Biochim Biophys Sin (Shanghai).
52:430–438. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Lu G, Shi W and Zheng H: Inhibition of
STAT6/Anoctamin-1 activation suppresses proliferation and invasion
of gastric cancer cells. Cancer Biother Radiopharm. 33:3–7.
2018.PubMed/NCBI
|
|
142
|
Yan Y, Ding X, Han C, Gao J, Liu Z, Liu Y
and Wang K: Involvement of TMEM16A/ANO1 upregulation in the
oncogenesis of colorectal cancer. Biochim Biophys Acta Mol Basis
Dis. 1868:1663702022. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Wang Q, Bai L, Luo S, Wang T, Yang F, Xia
J, Wang H, Ma K, Liu M, Wu S, et al: TMEM16A Ca(2+)-activated Cl(-)
channel inhibition ameliorates acute pancreatitis via the IP(3)
R/Ca(2+)/NFκB/IL-6 signaling pathway. J Adv Res. 23:25–35. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Zhang G, Shu Z, Yu J, Li J, Yi P, Wu B,
Deng D, Yan S, Li Y, Ren D, et al: High ANO1 expression is a
prognostic factor and correlated with an immunosuppressive tumor
microenvironment in pancreatic cancer. Front Immunol.
15:13412092024. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Guo JW, Liu X, Zhang TT, Lin XC, Hong Y,
Yu J, Wu QY, Zhang FR, Wu QQ, Shang JY, et al: Hepatocyte TMEM16A
deletion retards NAFLD progression by ameliorating hepatic glucose
metabolic disorder. Adv Sci (Weinh). 7:19036572020. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Guo J, Song Z, Yu J, Li C, Jin C, Duan W,
Liu X, Liu Y, Huang S, Tuo Y, et al: Hepatocyte-specific TMEM16A
deficiency alleviates hepatic ischemia/reperfusion injury via
suppressing GPX4-mediated ferroptosis. Cell Death Dis. 13:10722022.
View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Kondo R, Furukawa N, Deguchi A, Kawata N,
Suzuki Y, Imaizumi Y and Yamamura H: Downregulation of
Ca(2+)-activated Cl(-) channel TMEM16A mediated by angiotensin II
in cirrhotic portal hypertensive mice. Front Pharmacol.
13:8313112022. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Deng L, Yang J, Chen H, Ma B, Pan K, Su C,
Xu F and Zhang J: Knockdown of TMEM16A suppressed MAPK and
inhibited cell proliferation and migration in hepatocellular
carcinoma. Onco Targets Ther. 9:325–333. 2016.PubMed/NCBI
|
|
149
|
König B and Stauber T: Biophysics and
structure-function relationships of LRRC8-formed volume-regulated
anion channels. Biophys J. 116:1185–1193. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Sawicka M and Dutzler R: Regulators of
cell volume: The structural and functional properties of anion
channels of the LRRC8 family. Curr Opin Struct Biol. 74:1023822022.
View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Okada Y, Sabirov RZ, Sato-Numata K and
Numata T: Cell death induction and protection by activation of
ubiquitously expressed anion/cation channels. Part 1: Roles of
VSOR/VRAC in cell volume regulation, release of double-edged
signals and apoptotic/necrotic cell death. Front Cell Dev Biol.
8:6140402021. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Chen L, König B, Liu T, Pervaiz S,
Razzaque YS and Stauber T: More than just a pressure relief valve:
Physiological roles of volume-regulated LRRC8 anion channels. Biol
Chem. 400:1481–1496. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Konishi T, Shiozaki A, Kosuga T, Kudou M,
Shoda K, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, et
al: LRRC8A expression influences growth of esophageal squamous cell
carcinoma. Am J Pathol. 189:1973–1985. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Kurashima K, Shiozaki A, Kudou M, Shimizu
H, Arita T, Kosuga T, Konishi H, Komatsu S, Kubota T, Fujiwara H,
et al: LRRC8A influences the growth of gastric cancer cells via the
p53 signaling pathway. Gastric Cancer. 24:1063–1075. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Xu R, Hu Y, Xie Q, Zhang C, Zhao Y, Zhang
H, Shi H, Wang X and Shi C: LRRC8A is a promising prognostic
biomarker and therapeutic target for pancreatic adenocarcinoma.
Cancers (Basel). 14:55262022. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Lu P, Ding Q, Li X, Ji X, Li L, Fan Y, Xia
Y, Tian D and Liu M: SWELL1 promotes cell growth and metastasis of
hepatocellular carcinoma in vitro and in vivo. EBioMedicine.
48:100–116. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Zhang H, Deng Z, Zhang D, Li H, Zhang L,
Niu J, Zuo W, Fu R, Fan L, Ye JH and She J: High expression of
leucine-rich repeat-containing 8A is indicative of a worse outcome
of colon cancer patients by enhancing cancer cell growth and
metastasis. Oncol Rep. 40:1275–1286. 2018.PubMed/NCBI
|
|
158
|
Fujii T, Shimizu T, Yamamoto S, Funayama
K, Fujita K, Tabuchi Y, Ikari A, Takeshima H and Sakai H: Crosstalk
between Na(+),K(+)-ATPase and a volume-regulated anion channel in
membrane microdomains of human cancer cells. Biochim Biophys Acta
Mol Basis Dis. 1864:3792–3804. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Zhang H, Jing Z, Liu R, Shada Y, Shria S,
Cui S, Ren Y, Wei Y, Li L and Peng S: LRRC8A promotes the initial
development of oxaliplatin resistance in colon cancer cells.
Heliyon. 9:e168722023. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Zhang H, Cui S, Jing Z, Fu G, Liu R, Zhao
W, Xu L, Yu L, Bai Y, Lv C, et al: LRRC8A is responsible for
exosome biogenesis and volume regulation in colon cancer cells.
Biochem J. 480:701–713. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Wang HY, Shimizu T, Numata T and Okada Y:
Role of acid-sensitive outwardly rectifying anion channels in
acidosis-induced cell death in human epithelial cells. Pflugers
Arch. 454:223–233. 2007. View Article : Google Scholar
|
|
162
|
Osei-Owusu J, Kots E, Ruan Z, Mihaljević
L, Chen KH, Tamhaney A, Ye X, Lü W, Weinstein H and Qiu Z:
Molecular determinants of pH sensing in the proton-activated
chloride channel. Proc Natl Acad Sci USA. 119:e22007271192022.
View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Zhao J, Zhu D, Zhang X, Zhang Y, Zhou J
and Dong M: TMEM206 promotes the malignancy of colorectal cancer
cells by interacting with AKT and extracellular signal-regulated
kinase signaling pathways. J Cell Physiol. 234:10888–10898. 2019.
View Article : Google Scholar
|
|
164
|
Zhang L, Liu SY, Yang X, Wang YQ and Cheng
YX: TMEM206 is a potential prognostic marker of hepatocellular
carcinoma. Oncol Lett. 20:1742020.PubMed/NCBI
|
|
165
|
Huang X, Chen H, Michelsen K, Schneider S
and Shaffer PL: Crystal structure of human glycine receptor-α3
bound to antagonist strychnine. Nature. 526:277–280. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Clar DT and Maani CV: Physiology, Ligand
Gated Chloride Channel. StatPearls. StatPearls Publishing; Treasure
Island, FL: 2024
|
|
167
|
Sanjari Moghaddam H, Zare-Shahabadi A,
Rahmani F and Rezaei N: Neurotransmission systems in Parkinson's
disease. Rev Neurosci. 28:509–536. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Hsu YT, Chang YG and Chern Y: Insights
into GABA(A)ergic system alteration in Huntington's disease. Open
Biol. 8:1801652018. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Govindpani K, Calvo-Flores Guzmán B,
Vinnakota C, Waldvogel HJ, Faull RL and Kwakowsky A: Towards a
better understanding of GABAergic remodeling in Alzheimer's
disease. Int J Mol Sci. 18:18132017. View Article : Google Scholar : PubMed/NCBI
|
